Trial no.:
|
PACTR202407826889857 |
Date of Registration:
|
22/07/2024 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Immediate Implant Placement Using Tunneling Technique with Connective Tissue Graft versus Coated and Non-Coated DuraGen Matrix with Concentrated Growth Factors |
Official scientific title |
Immediate Implant Placement Using Tunneling Technique with Connective Tissue Graft versus Coated and Non-Coated DuraGen Matrix with Concentrated Growth Factors |
Brief summary describing the background
and objectives of the trial
|
Mid-facial recession has become a concern following immediate implant placement (IIP), it is now evident that labial bone contour cannot be maintained by placing implants in fresh extraction sockets. Dimensional changes, including the loss of labial soft tissues and mid-buccal mucosal recessions, seem to be expected following immediate placement. Several protocols have been advocated to minimize the possible esthetic impact of the post-extraction remodeling of the bundle bone. These include a correct 3dimensional implant position, a flapless approach, the use of an immediate implant-supported provisional restoration and filling the osseous gap with different biomaterials or thickening the mucosal compartment through soft tissue grafts. Consequently, due to lack of studies aboutthe effect of duragen collagen matrix in soft tissue augmentation around immediate implant placement in esthetic zone and based on the null hypothesis. The present randomized clinical trial will be conducted to evaluate whether this innovative soft tissue augmentation technique using duragen xenogenic collagen matrix alone or when enhanced with CGF versus SCTG has a better impact.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Oral Health |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
28/02/2022 |
Actual trial start date |
28/02/2022 |
Anticipated date of last follow up |
31/07/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
24 |
Actual target sample size (number of participants) |
|
Recruitment status |
Closed to recruitment,follow-up continuing |
Publication URL |
N/A |
|